Expert Commentary & Five-year View
Systemic lupus erythematosus presenting in adults and children shows important differences with respect to the prevalence of clinical and serological features. Furthermore, childhood-onset disease presents particular problems with respect to treatment complications and adherence. The next 5 years will see the reporting of drug trials of a variety of new biological agents that have good potential to reduce the burden of disease in both adults and children with SLE.
Author for correspondence
The Centre for Rheumatology, Room 331, The Windeyer Building, University College London, London W17 4JF, UK Tel.: +44 207 629 9684 Fax: +44 207 629 9143 firstname.lastname@example.org
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Expert Rev Clin Immunol. 2009;5(4):391-403. © 2009 Expert Reviews Ltd.
Cite this: Childhood- and adult-onset lupus: an update of similarities and differences - Medscape - Jul 01, 2009.